Literature DB >> 452968

Carcinoembryonic antigen (CEA) levels in patients with brain tumours.

E Miyake, M Yamashita, K Kitamura, F Ishigami.   

Abstract

Plasma and cerebrospinal fluid CEA determination was done in 97 patients with neurosurgical disorders. Elevated titres were found in 14 of 64 patients with brain tumours. CEA levels were elevated significantly in patients with metastatic brain tumours. Following treatment, the values fell in three patients with ependymoma, medulloblastoma, and unverified brain tumour. This study suggests that CEA levels may be of value in the differential diagnosis of primary and metastatic brain tumours, and useful in the evaluation of patients with brain tumours after treatment. CEA in the cerebrospinal fluid was absent in eight patients with brain tumours.

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 452968     DOI： 10.1007/bf01407680

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN： 0001-6268            Impact factor:   2.216


  15 in total

1.  Plasma levels of carcinoembryonic antigen in bronchial carcinoma and chronic bronchitis.

Authors:  R Pauwels; M Van der Straeten
Journal:  Thorax       Date:  1975-10       Impact factor: 9.139

2.  Demonstration of an antigen common to several varieties of neoplasia.

Authors:  P Lo Gerfo; J Krupey; H J Hansen
Journal:  N Engl J Med       Date:  1971-07-15       Impact factor: 91.245

3.  Carcinoembryonic antigen in patients with different cancers.

Authors:  G Reynoso; T M Chu; D Holyoke; E Cohen; T Nemoto; J J Wang; J Chuang; P Guinan; G P Murphy
Journal:  JAMA       Date:  1972-04-17       Impact factor: 56.272

4.  Carcinoembryonic antigen in human ovarian neoplasms.

Authors:  A Marchand; C M Fenoglio; R Pascal; R M Richart; S Bennett
Journal:  Cancer Res       Date:  1975-12       Impact factor: 12.701

5.  Carcinoembryonic antigen in hereditary adenomatosis of the colon and rectum.

Authors:  T Alm; B Wahren
Journal:  Scand J Gastroenterol       Date:  1975       Impact factor: 2.423

6.  CEA levels at recurrence and metastases; importance for detecting secondary disease.

Authors:  A Rieger; B Wahren
Journal:  Scand J Gastroenterol       Date:  1975       Impact factor: 2.423

7.  Carcinoembryonic antigen: clinical and historical aspects.

Authors:  E W Martin; W E Kibbey; L DiVecchia; G Anderson; P Catalano; J P Minton
Journal:  Cancer       Date:  1976-01       Impact factor: 6.860

8.  Carcinoembryonic antigen (CEA) in patients with carcinoma of the digestive tract.

Authors:  D Holyoke; G Reynoso; T M Chu
Journal:  Ann Surg       Date:  1972-10       Impact factor: 12.969

9.  Carcinoembryonic antigen (CEA) in patients with breast cancer.

Authors:  N M Borthwick; D W Wilson; P A Bell
Journal:  Eur J Cancer       Date:  1977-02       Impact factor: 9.162

10.  Specific carcinoembryonic antigens of the human digestive system.

Authors:  P Gold; S O Freedman
Journal:  J Exp Med       Date:  1965-09-01       Impact factor: 14.307
View more
  2 in total

Review 1.  Circulating glioma biomarkers.

Authors:  Johan M Kros; Dana M Mustafa; Lennard J M Dekker; Peter A E Sillevis Smitt; Theo M Luider; Ping-Pin Zheng
Journal:  Neuro Oncol       Date:  2014-09-24       Impact factor: 12.300

2.  The clinical relevance of locally produced carcinoembryonic antigen in cerebrospinal fluid.

Authors:  C Jacobi; H Reiber; K Felgenhauer
Journal:  J Neurol       Date:  1986-11       Impact factor: 4.849
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.